How challenges including Brexit, inadequate funding & insufficient patient sample sizes hinder…
SMi Reports: 8th Annual Orphan Drugs and Rare Diseases Conference to bring together pharmaceutical companies, non-profit organisations and orphan drug developers to explore alliances…
Read More...
Read More...
